Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)
CNY23.46
+0.54 (+2.36%)
CN SHZ Healthcare Drug Manufacturers - Specialty & Generic
Address
No.36, Shuxi Road 610036
Chengdu, CN
Chengdu, CN
CEO
Xiao Ke
Website
cnkh.com
IPO
2015-06-29
ISIN CNE1000020C4
Description
Chengdu Kanghong Pharmaceuticals Group Co., Ltd operates within China, focusing on the research, development, production, and marketing of a wide array of pharmaceutical goods. These include biologics, traditional Chinese medicines, and chemical drugs. The company's offerings span treatments for ophthalmic ailments, central nervous system conditions, digestive disorders, and other therapeutic areas. Founded in 1996, its corporate headquarters are located in Chengdu, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY23.46
+0.54 (+2.36%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
-0.10
Float Shares
358.13M
Free Float %
38.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.72% | -2.37% | -15.59% | -28.18% | -33.33% | -29.93% | -29.01% | +2.09% | -14.15% | -36.36% | +108.75% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
23.46
DCF (Unlevered)
64.94
+176.8%
DCF (Levered)
72.02
+207.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
20.72
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
9 / 10
Strong MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+3.0% Q1'26: -12.7% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-3.1% Q1'26: -23.3% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+26.7% Q1'26: +26.3% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+28.3% ★ Q1'26: +32.8% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+38.5% ★ Q1'26: +40.5% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+0.7% Q1'26: -1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×0.00× ★ Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.07B
est: 1.92B (+8.3%)
|
2.54B
est: 2.54B (-0.1%)
|
2.79B
est: 3.01B (-7.3%)
|
2.92B
est: 2.92B (-0.2%)
|
3.26B
est: 3.25B (+0.4%)
|
3.30B
est: 3.38B (-2.4%)
|
3.61B
est: 3.94B (-8.6%)
|
3.39B
est: 4.67B (-27.4%)
|
3.96B
est: 4.30B (-7.9%)
|
4.45B
est: 4.63B (-3.9%)
|
4.59B
est: 4.89B (-6.2%)
|
4.90B
4.90B – 4.90B
+0.2% YoY
|
5.13B
5.13B – 5.13B
+4.7% YoY
|
5.38B
5.38B – 5.38B
+4.8% YoY
|
| EBITDA |
475.72M
est: 366.37M (+29.8%)
|
580.53M
est: 486.51M (+19.3%)
|
747.87M
est: 575.23M (+30.0%)
|
722.24M
est: 559.34M (+29.1%)
|
783.73M
est: 620.83M (+26.2%)
|
-529.02M
est: 645.68M (-181.9%)
|
554.33M
est: 754.54M (-26.5%)
|
1.02B
est: 893.63M (+14.2%)
|
1.32B
est: 821.77M (+60.8%)
|
1.46B
est: 2.26B (-35.2%)
|
1.53B
est: 2.38B (-35.6%)
|
2.38B
2.38B – 2.38B
+0.2% YoY
|
2.50B
2.50B – 2.50B
+4.7% YoY
|
2.62B
2.62B – 2.62B
+4.8% YoY
|
| EBIT |
410.88M
est: 278.20M (+47.7%)
|
517.08M
est: 369.43M (+40.0%)
|
682.65M
est: 436.80M (+56.3%)
|
648.24M
est: 424.74M (+52.6%)
|
690.70M
est: 471.43M (+46.5%)
|
-647.52M
est: 490.30M (-232.1%)
|
407.00M
est: 572.96M (-29.0%)
|
864.46M
est: 678.58M (+27.4%)
|
1.10B
est: 624.02M (+76.4%)
|
1.23B
est: 1.98B (-37.9%)
|
1.30B
est: 2.09B (-38.1%)
|
2.10B
2.10B – 2.10B
+0.2% YoY
|
2.20B
2.20B – 2.20B
+4.7% YoY
|
2.30B
2.30B – 2.30B
+4.8% YoY
|
| Net Income |
393.81M
est: 404.13M (-2.6%)
|
496.75M
est: 519.49M (-4.4%)
|
644.20M
est: 668.64M (-3.7%)
|
694.94M
est: 775.35M (-10.4%)
|
718.19M
est: 757.50M (-5.2%)
|
-269.85M
est: 778.88M (-134.6%)
|
421.08M
est: 824.70M (-48.9%)
|
896.67M
est: 1.01B (-11.0%)
|
1.04B
est: 870.51M (+20.0%)
|
1.19B
est: 1.25B (-4.4%)
|
1.16B
est: 1.31B (-11.3%)
|
1.26B
1.26B – 1.26B
-3.5% YoY
|
1.38B
1.38B – 1.38B
+9.5% YoY
|
1.55B
1.55B – 1.55B
+12.0% YoY
|
| SGA |
1.39B
est: 973.08M (+43.2%)
|
1.73B
est: 1.29B (+33.9%)
|
1.59B
est: 1.53B (+4.0%)
|
1.76B
est: 1.49B (+18.6%)
|
1.97B
est: 1.65B (+19.5%)
|
1.89B
est: 1.71B (+10.3%)
|
1.79B
est: 2.00B (-10.9%)
|
1.71B
est: 2.37B (-27.9%)
|
1.94B
est: 2.18B (-11.0%)
|
2.12B
est: 2.06B (+2.6%)
|
1.19B
est: 2.18B (-45.1%)
|
2.18B
2.18B – 2.18B
+0.2% YoY
|
2.28B
2.28B – 2.28B
+4.7% YoY
|
2.39B
2.39B – 2.39B
+4.8% YoY
|
| EPS |
0.48
est: 0.44 (+8.8%)
|
0.57
est: 0.57 (+0.5%)
|
0.74
est: 0.73 (+1.4%)
|
0.80
est: 0.85 (-5.5%)
|
0.82
est: 0.83 (-0.8%)
|
-0.29
est: 0.85 (-134.1%)
|
0.46
est: 0.90 (-48.9%)
|
0.98
est: 1.10 (-10.9%)
|
1.14
est: 0.95 (+20.0%)
|
1.30
est: 1.35 (-3.7%)
|
1.26
est: 1.42 (-11.3%)
|
1.37
1.37 – 1.37
-3.5% YoY
|
1.50
1.50 – 1.50
+9.5% YoY
|
1.68
1.68 – 1.68
+12.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 2/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.03B
OE per share TTM
1.11
Owner's Yield
5.33%
Maintenance CapEx ratio
50.04%
Maint CapEx / Avg PPE
55.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 33 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | JPMorgan Diversified Return Emerging Markets Equity ETF JPEM | 0.11% | 408.0K | 0.44% |
| 2 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.08% | 28.9K | 0.65% |
| 3 | State Street SPDR S&P China ETF GXC | 0.03% | 118.2K | 0.59% |
| 4 | iShares Emerging Markets Equity Factor ETF EMGF | 0.02% | 378.8K | 0.26% |
| 5 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.01% | 4.9K | 0.15% |
| 6 | Franklin FTSE China ETF FLCH | 0.01% | 21.7K | 0.19% |
| 7 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.01% | 30.5K | 0.49% |
| 8 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 91.8K | 0.19% |
| 9 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 33.3K | 0.44% |
| 10 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 68.1K | 0.46% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
290.4K
Shares Outstanding
921.32M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jian Jun Zhong | Chief Financial Officer & Vice President | — | male |
| Jian Rong Zhong | Vice President & Director | — | female |
| Jin Qun Yin | Vice President & Director | — | male |
| Kang Deng | Board Secretary & Assistant to the President | — | male |
| Xiao Ke | GM, President & Director | — | male |
| Yanhua Xu | Vice President | — | female |
| Ying Mei He | Chief Accounting Officer | — | — |
| Zhigang Jiang | Sponsor Representative | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002773.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
